11P Hypomagnesaemia in the context of cetuximab/panitumumab and proton pump inhibitor therapy

MLA

J. Rowe, et al. “11P Hypomagnesaemia in the Context of Cetuximab/Panitumumab and Proton Pump Inhibitor Therapy.” Annals of Oncology, vol. 27, Dec. 2016, pp. ix3-ix4. EBSCOhost, https://doi.org/10.1016/s0923-7534(21)00173-3.

APA

J. Rowe, P. Connolly, R. Joshi, & T. Foo. (2016). 11P Hypomagnesaemia in the context of cetuximab/panitumumab and proton pump inhibitor therapy. Annals of Oncology, 27, ix3-ix4. https://doi.org/10.1016/s0923-7534(21)00173-3

Chicago

J. Rowe, P. Connolly, R. Joshi, and T. Foo. 2016. “11P Hypomagnesaemia in the Context of Cetuximab/Panitumumab and Proton Pump Inhibitor Therapy.” Annals of Oncology 27 (December): ix3-ix4. doi:10.1016/s0923-7534(21)00173-3.